Insider Transactions Report for Simon N.R. Harford

On April 27, 2026, Simon N.R. Harford, Chief Financial Officer of AMICUS THERAPEUTICS, INC. (FOLD), reported the disposition of 143,595 shares of Common Stock at a price of $14.50 per share. This disposition was part of the acquisition of the Issuer by BioMarin Pharmaceutical Inc. In addition to the stock disposition, Harford also had stock options (right to buy) for 189,043, 99,073, and 150,517 shares of Common Stock cancelled and converted into the right to receive a cash payment. These options vested in full in connection with the merger. All reported transactions resulted in 0 shares owned following the transactions.